Joe Springer's  Instablog

Joe Springer
  • on Retirement
Send Message
It is very hard or impossible to time the broad market consistently — there are no famous investors that got rich by consistently knowing what the broad market would do next. This only makes sense, as there are just too many variables in the broad market. But there are many famous investors who... More
My company:
My blog:
The Wall Street Exclusive
  • The Tonning Salon 6 comments
    Apr 10, 2014 8:00 PM | about stocks: TNXP

    We got several questions about the Tonix (NASDAQ:TNXP) filings from yesterday, which we noted were not dilutive, just administrative. We talked with one of our experienced and knowledgeable brethren about the filings, and he had this to say:

    Both Post-Effective Amendments today were to register warrants under Form S-3, the first to register the warrants from the IPO, the second to register the warrants from the accredited investor and PIPE deals in the pink sheet days. The effect is that Leland won't have to do an 8K each time unregistered shares are issued pursuant to warrant exercise equal to 5% of outstanding common, because the shares will already be exercised. Most of the $4.25 warrants are held by the insiders, Technology Partners and Broadfin and at least as to the first two aren't going to be exercised soon and even if they were they could have been exercised under the Form S-1 registrations. The rest of the warrants are at $12, $20 and $25 and are not expiring anytime soon, so they are unlikely to be exercised. The only warrants that expired were the $8.00s and only Technology Partners was able to exercise when the stock price justified it because they bought later and even they were constrained by the beneficial ownership limitation. Probably just a formality, one of the many things they've done lately to dot "i"s and cross "t"s, but its remotely possible something is up.

    In comparing to the original registrations the remarkable thing is how many individual accredited investors, family trusts and the like, bought into the early offerings in relatively small quantities and while some have sold some shares, most are still completely in. It looks like management and Dawson sold to a lot of friends and family and that typically is an expression of confidence on both sides.

    I've been thinking about Technology Partners having gone all in in this deal and I think they have come to the 95% certainty that you did. I think they keyed into the open-label continuation enrollment. Unlikely that significant patient numbers would have agreed to participate if the side-effects were troublesome or if they didn't perceive benefit. Plus the secondary itself removed a huge amount of risk from this deal. I think it's a pretty good bet the deal was agreed to by Technology Partners and the company with or without Roth as an intermediary..

    Disclosure: I am long TNXP.

    Stocks: TNXP
Back To Joe Springer's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (6)
Track new comments
  • Brandon H.
    , contributor
    Comments (8) | Send Message
    Thank You Joe. I am also long on TNXP. Curious to see if you are still bullish on GTXI. Looks like a good time to buy?
    2 May 2014, 06:26 PM Reply Like
  • Joe Springer
    , contributor
    Comments (2631) | Send Message
    Author’s reply » Thank you Brandon, love your icon! I have not paid as much attention to GTXI lately, but this sure was bullish:

    2 May 2014, 06:30 PM Reply Like
  • Brandon H.
    , contributor
    Comments (8) | Send Message
    Great updates on TNXP the last few days:) Can't wait for more good days ahead! And thanks for the link on the GTXI article. Still watching that one
    10 May 2014, 02:23 PM Reply Like
  • M Cuturic
    , contributor
    Comments (393) | Send Message
    If you had to choose TNXP or ADMS, which would you choose and why?
    31 May 2014, 06:10 AM Reply Like
  • Joe Springer
    , contributor
    Comments (2631) | Send Message
    Author’s reply » I would choose TNXP, because I don't know anything about ADMS.


    ADMP on the other hand...
    31 May 2014, 10:48 AM Reply Like
  • Joe Springer
    , contributor
    Comments (2631) | Send Message
    Author’s reply » I love all my children (and General Hospital and Guiding Light) M Cuturic, tough to choose.


    ADMP is closer to the market, TNXP probably has just about the best patent situation you could hope for, they both have very high upside and multiple shots on goal.


    One thing for TNXP is that it has the BESTFIT results catalyst this year, in my opinion it will make a new all time high and multi-bag from here. ADMP is not too far behind as early next year should have POC trial results and PFS FDA answer (high probability of success).


    I think they are both winners...
    31 May 2014, 10:54 AM Reply Like
Full index of posts »
Latest Followers


  • $AMNF $3.8 million cash at end of Q1: Should be able to fund expansion
    May 27, 2016
  • Look $MIK vs other brick&mortars Retail selloff is buy in Amazonprotected MIK 16.3 PE DivCatlyst C
    May 11, 2016
  • $ADMP Adamis License Agreement with Allergan plc Subsidiary for Epinephrine Pre-Filled Syringe Carlo is a dealmaker
    May 10, 2016
More »

Latest Comments

Most Commented
  1. Fire Away ( Comments)
  2. I Am You See ( Comments)
  3. What Is Tonix Worth? ( Comments)
  4. Hooked On Tonix ( Comments)
  5. Seattle Super-Tonix ( Comments)
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.